Unitedhealth Group Inc header image

Unitedhealth Group Inc

UNH

Equity

ISIN null / Valor 1078451

New York Stock Exchange, Inc (2025-10-17)
USD 356.60-0.02%

Unitedhealth Group Inc
UMushroom community rating:

star star star star star
3.21 4 votes No rating yet
NegativeNeutralPositive

About company

UnitedHealth Group Inc. is a diversified health care company, operating through its two main subsidiaries, Optum and UnitedHealthcare, to foster a modern, efficient health system. Optum focuses on improving health care delivery through technology and data, providing tools and support to enhance the health of individuals and communities. UnitedHealthcare, on the other hand, offers a comprehensive range of health benefits, including affordable coverage and access to quality care, aimed at simplifying the health care experience for consumers. UnitedHealth Group is committed to serving the health care needs of over 152 million people worldwide, promoting a value-based care system that emphasizes compassionate and equitable treatment. The company's efforts are geared towards making high-quality care both affordable and accessible, leveraging cross-sector collaboration and technological innovation to meet consumer needs and improve the overall health care landscape.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (03.09.2025):

UnitedHealth Group Inc reported its second quarter of 2025 results and provided an updated outlook for the year. The company has adjusted its financial guidance, reflecting the performance of the first half of the year and anticipates a return to earnings growth in 2026.

Updated 2025 Revenue Guidance

UnitedHealth Group Inc has revised its 2025 revenue expectations to between $445.5 billion and $448.0 billion, based on the latest first half performance and projected care trends for the remainder of the year.

Adjusted Earnings Per Share

The company now forecasts net earnings of at least $14.65 per share and adjusted earnings of at least $16.00 per share for 2025, incorporating higher realized and anticipated care trends.

Path to Future Growth

UnitedHealth Group Inc expects to strengthen its operating disciplines and return to earnings growth in 2026, positioning itself for sustained growth and continued support for its customers and partners.

Upcoming Investor Teleconference

The company will provide additional details regarding its current and planned actions during a teleconference for analysts and investors scheduled today at 8 a.m. ET.

Summarized from source with an LLMView Source

Key figures

-37.0%1Y
-31.7%3Y
8.09%5Y

Performance

51.6%1Y
34.8%3Y
30.5%5Y

Volatility

Market cap

322963 M

Market cap (USD)

Daily traded volume (Shares)

8,608,378

Daily traded volume (Shares)

1 day high/low

509.71 / 500.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.21

4 votes
Performance:
starstarstarstarstar
2.86
Innovation:
starstarstarstarstar
2.14
Society:
starstarstarstarstar
3.07
Nature:
starstarstarstarstar
3.00
Constantin Cremer
Switzerland, 19 Oct 2025
star star star star star
Very complex business -> hard to understand and anticipate future performance + highly regulated industry
Federico Ferrari
Switzerland, 14 Oct 2025
star star star star star
Positive outlook
Eduard Hüsler
Switzerland, 05 Mar 2025
star star star star star
Lösungen rund um Gesundheit und Gesundheitsvorsorge sind immer wichtiger.

EQUITIES OF THE SAME SECTOR

Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%USD 146.78
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.34%SEK 29.34
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.51%EUR 62.52
Patterson Companies Inc
Patterson Companies Inc Patterson Companies Inc Valor: 1896660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 31.33
Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Valor: 32193461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.54%USD 36.81
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 54.92
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.04%USD 35.27
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%USD 19.92
dentalcorp Holdings Ltd
dentalcorp Holdings Ltd dentalcorp Holdings Ltd Valor: 111405816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CAD 10.89
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.70%USD 15.06